NCT06845358View on ClinicalTrials.gov

Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG TICE strain

BCG TICE strain is an attenuated, live culture preparation of the BCG strain of Mycobacterium bovis.

OTHER

Sodium Chloride, 0.9%

0.9% Sodium Chloride Injection

OTHER

Sterile Water for Injection

A sterile, nonpyrogenic preparation of water for injection which contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH